SCHEMBL1930675

SCHEMBL1930675

O=C(OS(=O)(=O)OC(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27831682 0.85
SCHEMBL6601319 0.80 TSHR (0.37) ALDH1A1L3MBTL1
SCHEMBL144168 0.78 USP2 (0.32)
SCHEMBL17267891 0.78
SCHEMBL7182154 0.78 CA1 (0.37)
SCHEMBL576147 0.78 ALDH1A1 (0.35) ALDH1A1L3MBTL1
SCHEMBL18762982 0.76 FAAH (0.31)
SCHEMBL28539958 0.76 ATR (0.31)
SCHEMBL28232140 0.76 MEN1 (0.32) ALDH1A1
SCHEMBL577177 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497354-B2 Efficient conversion of methane to methanesulfonic acid via trifluoroacetylsulfuric acid UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2025-12-16 US claimed
US-20230242477-A1 EFFICIENT CONVERSION OF METHANE TO METHANESULFONIC ACID VIA TRIFLUOROACETYLSULFURIC ACID UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-08-03 US claimed
CN-110461905-A Poly- (ether ether ketone) copolymer of block and corresponding synthetic method and product SOLVAY SPECIALTY POLYMERS IT 2019-11-15 CN claimed
US-20130012736-A1 METHYLIDENE MALONATE PROCESS OPTMED, INC. (US) 2013-01-10 US claimed
US-20090124814-A1 Process for preparing telmisartan PERLMAN NURIT 2009-05-14 US claimed
EP-1699765-A1 PROCESS FOR PREPARING TELMISARTAN Teva Pharmaceutical Industries Ltd (IL) 2006-09-13 EP claimed
US-20060094883-A1 high yields, low cost process; easy solvent extraction; nontoxic, safe, environmentally friendly, low boiling point organic solvents; 1,7'-dimethyl-2'-propyl-1H,3'H-[2,5']bibenzoimidazolyl is reacted with 4'bromomethyl-biphenyl-2-carboxylic acid alkyl ester; industrial scale; hydrolysis TEVA PHARMACEUTICALS USA, INC. 2006-05-04 US claimed
WO-2006044648-A1 PROCESS FOR PREPARING TELMISARTAN TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2006-04-27 WO claimed
US-12497354-B2 Efficient conversion of methane to methanesulfonic acid via trifluoroacetylsulfuric acid UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2025-12-16 US disclosed
US-20230242477-A1 EFFICIENT CONVERSION OF METHANE TO METHANESULFONIC ACID VIA TRIFLUOROACETYLSULFURIC ACID UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-08-03 US disclosed
CN-110461905-A Poly- (ether ether ketone) copolymer of block and corresponding synthetic method and product SOLVAY SPECIALTY POLYMERS IT 2019-11-15 CN disclosed
CN-108699032-A Polycyclic T L R7/8 antagonists and their use in treating immune disorders 默克专利有限公司 2018-10-23 CN disclosed
US-9789125-B2 Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid ALLERGAN HOLDINGS UNLIMITED COMPANY (IE) 2017-10-17 US disclosed
CN-103649045-B For the manufacture of the method originating in organic acid dihalo diphenyl sulfone SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2016-03-16 CN disclosed
CN-103649045-A Process for the manufacture of dihalodiphenylsulfones starting from organic acids SOLVAY SPECIALTY POLYMERS USA 2014-03-19 CN disclosed
US-7956209-B2 Polyisocyanates containing allophanate and silane groups BAYER MATERIALSCIENCE AG (DE) 2011-06-07 US disclosed
US-20090018302-A1 POLYISOCYANATES CONTAINING ALLOPHANATE AND SILANE GROUPS BAYER MATERIALSCIENCE AG (DE) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012736-A1 METHYLIDENE MALONATE PROCESS MPHOSPH6, ME1, MGAM ALDH1A1 1618/4885L3MBTL1 958/4885
US-20060094883-A1 high yields, low cost process; easy solvent extraction; nontoxic, safe, environmentally friendly, low boiling point organic solvents; 1,7'-dimethyl-2'-propyl-1H,3'H-[2,5']bibenzoimidazolyl is reacted with 4'bromomethyl-biphenyl-2-carboxylic acid alkyl ester; industrial scale; hydrolysis AGT, ACE, REN ALDH1A1 1639/4885L3MBTL1 3642/4885
US-20230242477-A1 EFFICIENT CONVERSION OF METHANE TO METHANESULFONIC ACID VIA TRIFLUOROACETYLSULFURIC ACID HAO2, TST, HAGH ALDH1A1 1952/4885L3MBTL1 3856/4885
US-20090124814-A1 Process for preparing telmisartan AGT, ACE, REN ALDH1A1 2133/4885L3MBTL1 4842/4885
US-12497354-B2 Efficient conversion of methane to methanesulfonic acid via trifluoroacetylsulfuric acid HAO2, TST, HAGH ALDH1A1 1952/4885L3MBTL1 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.